Canadian Tobacco Alcohol and Drugs (CTADS): 2015 supplementary tables
Corrections posted March 2017
- Table 1. Smoking status and average number of cigarettes smoked per day, by age group and sex, 2015
- Table 2. Smoking status and average number of cigarettes smoked per day, by province, age group and sex, 2015
- Table 3. Nicotine dependence among daily smokers by age group and sex, 2015
- Table 4. Quit attempts in the past 12 months, by age group and sex, daily smokers, 2015
- Table 5. Quit rates among ever smokers by time since quit, by age group and sex, 2015
- Table 6. Stages of change, categories of readiness to quit smoking, by age group and sex, among ever smokers (current and former smokers combined), 2015
- Table 7. Exposure of children at home to Environmental Tobacco Smoke (ETS), by province and age group, 2015
- Table 8. Past-30-day use of cigarettes, any tobacco product, e-cigarettes, by age group and sex, 2015
- Table 9. E-cigarette status, by age group and sex, 2015
- Table 10. Past-30-day use of individual tobacco products and e-cigarettes, by age group and sex, 2015
- Table 11. Illicit drug use (past 12-month and lifetime), by age group and sex, 2015
- Table 12. Psychoactive pharmaceutical drug use (past 12-month), by age group and sex, 2015
- Table 13. Drug harms, by age group and sex, 2015
- Table 14. Illicit drug use (past 12-month and lifetime), by province, 2015
- Table 15. Alcohol indicators, by age group and sex, 2015
- Table 16. Alcohol indicators, by province, 2015
- Table 17. Description of the sample, 2015
Sex | Age group (years) | Population estimate ('000) |
Current smokers (%) |
Daily smokers (%) |
Occasional smokers (%) |
Former smokers (%) |
Never Smoked (%) |
Average cigarettes smoked per dayTable 1 Footnote 1 |
---|---|---|---|---|---|---|---|---|
Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2015. [95% confidence intervals in brackets] Table 1 Footnotes
|
||||||||
Total | All age groups | 29,670 | 13.0 [12.0-14.0] |
9.4 [8.4-10.3] |
3.7 [3.1-4.2] |
27.2 [25.9-28.6] |
59.8 [58.3-61.3] |
13.8 [12.9-14.6] |
Male | 14,642 | 15.6 [14.0-17.3] |
10.9 [9.4-12.4] |
4.8 [3.9-5.7] |
30.1 [28.0-32.2] |
54.2 [52.0-56.5] |
15.2 [14.0-16.3] |
|
Female | 15,029 | 10.4 [9.2-11.6] |
7.9 [6.8-9.0] |
2.5 [2.0-3.1] |
24.4 [22.7-26.1] |
65.2 [63.2-67.2] |
11.9 [10.7-13.1] |
|
Both sexes | 15-17 | 1,191 | 6.1 [3.9-8.2] |
2.8 [1.1-4.4] |
3.3 [1.9-4.7] |
92.4 [89.7-95.2] |
||
18-19 | 887 | 14.5 [10.9-18.2] |
6.2 [3.7-8.8] |
8.3 [5.6-11.0] |
83.8 [80.2-87.4] |
12.0 [8.9-15.1] |
||
15-19 | 2,078 | 9.7 [7.7-11.7] |
4.3 [2.8-5.7] |
5.4 [4.0-6.9] |
88.8 [86.6-91.0] |
11.6 [9.2-14.1] |
||
20-22 | 1,446 | 18.1 [15.1-21.2] |
9.0 [6.8-11.2] |
9.1 [6.8-11.4] |
5.8 [3.6-7.9] |
76.1 [72.6-79.6] |
11.1 [9.6-12.5] |
|
23-24 | 1,002 | 19.0 [14.4-23.5] |
12.0 [8.0-15.9] |
7.0 [4.4-9.6] |
9.4 [6.2-12.7] |
71.6 [66.6-76.6] |
12.6 [10.0-15.2] |
|
20-24 | 2,448 | 18.5 [15.8-21.1] |
10.2 [8.0-12.4] |
8.2 [6.5-10.0] |
7.3 [5.4-9.2] |
74.2 [71.2-77.3] |
11.8 [10.3-13.4] |
|
25-34 | 4,933 | 14.4 [11.3-17.5] |
9.6 [6.8-12.3] |
4.9 [3.1-6.7] |
15.6 [12.2-19.0] |
70.0 [65.9-74.1] |
12.1 [9.8-14.5] |
|
35-44 | 4,722 | 15.4 [12.2-18.6] |
11.6 [8.7-14.5] |
3.8 [2.3-5.3] |
24.9 [21.2-28.6] |
59.7 [55.4-64.0] |
13.9 [11.9-15.9] |
|
45-54 | 5,157 | 13.0 [10.6-15.4] |
9.7 [7.7-11.8] |
3.3 [2.0-4.6] |
29.2 [25.6-32.8] |
57.7 [53.9-61.6] |
15.2 [13.7-16.8] |
|
55+ | 10,332 | 10.6 [9.0-12.1] |
8.9 [7.5-10.2] |
1.7 [0.9-2.5] |
42.7 [40.2-45.2] |
46.7 [44.2-49.3] |
14.5 [13.0-16.1] |
|
25+ | 25,144 | 12.7 [11.6-13.9] |
9.7 [8.6-10.8] |
3.1 [2.4-3.7] |
31.3 [29.7-32.9] |
56.0 [54.2-57.7] |
14.1 [13.1-15.0] |
|
Male | 15-17 | 640 | 6.3 [3.1-9.5] |
91.3 [86.6-96.1] |
||||
18-19 | 428 | 17.9 [12.5-23.3] |
7.8 [4.0-11.6] |
10.1 [6.3-13.9] |
80.3 [74.8-85.8] |
10.6 [7.0-14.1] |
||
15-19 | 1,068 | 11.0 [8.0-13.9] |
5.1 [2.8-7.4] |
5.9 [4.0-7.7] |
86.9 [83.3-90.5] |
10.5 [7.5-13.6] |
||
20-22 | 747 | 22.7 [18.1-27.3] |
11.2 [8.1-14.3] |
11.5 [7.8-15.2] |
5.5 [2.4-8.7] |
71.8 [66.6-77.0] |
12.2 [10.3-14.1] |
|
23-24 | 506 | 22.1 [15.0-29.2] |
12.9 [6.9-19.0] |
9.1 [4.9-13.4] |
11.1 [5.7-16.5] |
66.8 [58.9-74.7] |
12.5 [8.9-16.2] |
|
20-24 | 1,253 | 22.4 [18.4-26.5] |
12.0 [8.6-15.2] |
10.5 [7.8-13.3] |
7.8 [4.9-10.7] |
69.8 [65.2-74.3] |
12.4 [10.4-14.3] |
|
25-34 | 2,464 | 19.1 [14.0-24.2] |
12.0 [7.7-16.4] |
7.1 [3.9-10.2] |
14.8 [9.4-20.1] |
66.2 [59.7-72.6] |
14.7 [12.0-17.4] |
|
35-44 | 2,350 | 19.7 [14.2-25.3] |
15.0 [9.9-20.2] |
4.7 [2.2-7.1] |
27.6 [22.0-33.3] |
52.6 [46.1-59.1] |
14.9 [12.0-17.7] |
|
45-54 | 2,581 | 14.4 [10.9-18.0] |
9.8 [7.1-12.5] |
4.7 [2.1-7.2] |
31.8 [26.2-37.3] |
53.8 [48.0-59.5] |
17.2 [14.9-19.5] |
|
55+ | 4,925 | 11.9 [9.6-14.2] |
9.9 [7.8-12.0] |
2.1 [1.0-3.1] |
49.8 [45.9-53.8] |
38.3 [34.4-42.2] |
16.0 [13.7-18.3] |
|
25+ | 12,320 | 15.4 [13.4-17.3] |
11.3 [9.5-13.0] |
4.1 [3.0-5.2] |
34.8 [32.3-37.3] |
49.8 [47.2-52.5] |
15.6 [14.3-16.9] |
|
Female | 15-17 | 551 | 5.8 [3.0-8.6] |
93.7 [90.9-96.6] |
||||
18-19 | 459 | 11.4 [6.4-16.4] |
6.6 [2.7-10.5] |
87.1 [82.1-92.1] |
||||
15-19 | 1,010 | 8.3 [5.6-11.1] |
3.4 [1.6-5.2] |
4.9 [2.8-7.1] |
90.7 [88.0-93.5] |
14.1 [10.5-17.6] |
||
20-22 | 699 | 13.3 [9.0-17.5] |
6.7 [3.6-9.8] |
6.6 [3.8-9.4] |
6.1 [3.2-8.9] |
80.7 [75.9-85.4] |
8.6 [6.9-10.3] |
|
23-24 | 496 | 15.8 [9.9-21.6] |
11.0 [5.7-16.2] |
7.7 [3.8-11.6] |
76.5 [69.7-83.2] |
12.7 [8.6-16.7] |
||
20-24 | 1,195 | 14.3 [10.8-17.9] |
8.5 [5.5-11.4] |
5.9 [3.8-7.9] |
6.8 [4.4-9.1] |
79.0 [75.0-82.9] |
11.0 [8.2-13.7] |
|
25-34 | 2,469 | 9.8 [6.2-13.3] |
7.1 [3.7-10.5] |
16.4 [12.0-20.9] |
73.8 [68.5-79.1] |
7.8 [4.9-10.8] |
||
35-44 | 2,372 | 11.1 [8.0-14.2] |
8.2 [5.4-10.9] |
22.3 [17.4-27.1] |
66.6 [61.2-72.1] |
12.3 [10.0-14.5] |
||
45-54 | 2,575 | 11.6 [8.5-14.7] |
9.7 [6.7-12.7] |
1.9 [0.9-3.0] |
26.6 [21.9-31.4] |
61.8 [56.5-67.0] |
13.3 [11.3-15.3] |
|
55+ | 5,408 | 9.4 [7.2-11.5] |
7.9 [6.1-9.8] |
36.2 [33.2-39.2] |
54.4 [51.1-57.8] |
12.7 [10.7-14.7] |
||
25+ | 12,824 | 10.2 [8.8-11.6] |
8.2 [6.9-9.4] |
2.0 [1.4-2.7] |
27.9 [25.9-29.9] |
61.9 [59.9-64.2] |
11.9 [10.6-13.2] |
Smoking Status | Canada | NL | PE | NS | NB | QC | ON | MB | SK | AB | BC |
---|---|---|---|---|---|---|---|---|---|---|---|
Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2015. [95% confidence intervals in brackets] Table 2 Footnotes
|
|||||||||||
Sample Size | 15,154 | 1,420 | 1,428 | 1,437 | 1,430 | 1,547 | 1,451 | 1,537 | 1,598 | 1,709 | 1,597 |
Current smokers | |||||||||||
Total | 13.0 [12.0-14.0] |
18.5 [15.8-21.1] |
12.9 [10.9-15.0] |
17.8 [14.9-20.6] |
14.2 [11.4-17.0] |
14.2 [11.9-16.5] |
11.3 [9.2-13.5] |
14.8 [12.4-17.2] |
16.9 [14.4-19.4] |
15.8 [13.5-18.1] |
10.2 [8.4-11.9] |
15-19 | 9.7 [7.7-11.7] |
13.2 [8.6-17.8] |
12.9 [7.7-18.1] |
12.7 [8.6-16.8] |
13.7 [9.2-18.3] |
||||||
20-24 | 18.5 [15.8-21.1] |
25.2 [18.0-32.5] |
15.4 [10.5-20.4] |
19.8 [14.5-25.1] |
21.1 [14.3-27.9] |
20.3 [14.7-25.8] |
17.9 [12.7-23.1] |
19.5 [14.4-24.5] |
24.3 [17.6-30.9] |
19.0 [14.3-23.7] |
13.8 [9.1-18.6] |
25-44 | 14.9 [12.7-17.1] |
18.2 [13.2-23.2] |
15.9 [10.8-21.0] |
23.7 [16.7-30.7] |
15.6 [10.7-20.6] |
14.6 [10.3-18.9] |
13.7 [9.0-18.4] |
15.2 [10.3-20.1] |
18.8 [14.0-23.6] |
17.0 [12.6-21.5] |
13.4 [9.2-17.5] |
45+ | 11.4 [10.1-12.7] |
18.5 [15.0-22.0] |
11.1 [8.6-13.7] |
15.8 [12.6-18.9] |
13.4 [9.7-17.2] |
13.2 [10.1-16.3] |
9.2 [6.6-11.8] |
14.1 [10.9-17.2] |
14.8 [11.3-18.2] |
15.1 [12.0-18.3] |
8.2 [6.0-10.3] |
Male (15+) | 15.6 [14.0-17.3] |
23.1 [19.0-27.2] |
16.2 [12.7-19.7] |
21.0 [16.4-25.5] |
16.3 [12.2-20.4] |
17.8 [14.0-21.6] |
13.3 [10.0-16.6] |
18.5 [14.6-22.3] |
19.0 [15.2-22.9] |
18.9 [15.2-22.7] |
12.2 [9.4-15.1] |
15-24 | 17.1 [14.5-19.8] |
25.1 [18.1-32.1] |
19.0 [13.8-24.1] |
19.6 [14.3-24.9] |
18.0 [11.6-24.4] |
19.8 [14.2-25.3] |
16.1 [11.1-21.1] |
17.5 [12.9-22.1] |
23.2 [16.4-30.1] |
17.8 [12.8-22.8] |
12.6 [8.1-17.1] |
25+ | 15.4 [13.4-17.3] |
22.8 [18.2-27.3] |
15.7 [11.7-19.7] |
21.2 [15.9-26.5] |
16.0 [11.4-20.6] |
17.5 [13.1-21.8] |
12.7 [9.0-16.5] |
18.7 [14.1-23.2] |
18.2 [13.8-22.6] |
19.1 [14.9-23.4] |
12.2 [8.9-15.4] |
Female (15+) | 10.4 [9.2-11.6] |
14.0 [10.8-17.2] |
9.9 [7.4-12.3] |
14.8 [11.4-18.1] |
12.2 [9.0-15.4] |
10.7 [8.1-13.3] |
9.5 [6.8-12.1] |
11.2 [8.5-14.0] |
14.7 [11.8-17.7] |
12.6 [9.8-15.3] |
8.2 [6.0-10.3] |
15-24 | 11.6 [9.3-13.8] |
14.1 [8.7-19.6] |
14.9 [9.9-19.9] |
15.1 [10.3-19.8] |
11.4 [7.3-15.5] |
||||||
25+ | 10.2 [8.8-11.6] |
14.2 [10.8-17.7] |
10.0 [7.2-12.7] |
15.9 [12.1-19.7] |
12.4 [8.8-16.0] |
10.1 [7.3-13.0] |
9.2 [6.2-12.2] |
10.5 [7.4-13.6] |
14.7 [11.3-18.0] |
12.8 [9.7-15.9] |
8.1 [5.6-10.6] |
Former smokers | |||||||||||
Total | 27.2 [25.9-28.6] |
30.0 [26.9-33.1] |
32.4 [29.6-35.2] |
32.3 [29.2-35.5] |
31.8 [28.4-35.2] |
30.7 [27.8-33.6] |
26.0 [23.2-28.8] |
25.3 [22.5-28.1] |
25.7 [23.0-28.3] |
23.1 [20.6-25.7] |
26.9 [24.0-29.7] |
15-19 | |||||||||||
20-24 | 7.3 [5.4-9.2] |
||||||||||
25-44 | 20.2 [17.7-22.7] |
20.6 [15.1-26.1] |
21.1 [15.5-26.8] |
24.9 [18.4-31.4] |
21.1 [14.8-27.4] |
23.1 [17.7-28.4] |
21.5 [16.2-26.7] |
20.7 [15.5-26.0] |
14.2 [10.5-18.0] |
14.6 [10.6-18.6] |
17.5 [12.6-22.3] |
45+ | 38.2 [36.2-40.2] |
40.6 [36.3-44.9] |
44.8 [40.9-48.7] |
43.3 [39.0-47.7] |
43.2 [38.5-48.0] |
41.9 [37.6-46.2] |
35.3 [31.2-39.5] |
35.3 [31.2-39.4] |
40.5 [36.0-45.1] |
36.5 [31.9-41.1] |
38.8 [34.5-43.1] |
Male (15+) | 30.1 [28.0-32.2] |
33.9 [29.5-38.3] |
32.1 [27.9-36.3] |
36.2 [31.7-40.7] |
35.6 [30.2-41.0] |
32.1 [28.0-36.3] |
30.7 [26.2-35.1] |
27.1 [22.8-31.4] |
27.3 [23.5-31.1] |
25.1 [21.3-29.0] |
28.2 [23.7-32.7] |
15-24 | 5.2 [3.3-7.1] |
||||||||||
25+ | 34.8 [32.3-37.3] |
38.5 [33.4-43.5] |
36.7 [31.8-41.7] |
41.9 [36.6-47.2] |
40.1 [34.0-46.3] |
37.0 [32.2-41.8] |
35.6 [30.3-40.9] |
31.7 [26.6-36.9] |
31.8 [27.3-36.3] |
28.6 [24.1-33.2] |
32.8 [27.5-38.1] |
Female (15+) | 24.4 [22.7-26.1] |
26.3 [22.3-30.3] |
32.7 [29.1-36.4] |
28.6 [24.2-33.0] |
28.2 [24.0-32.3] |
29.3 [25.5-33.2] |
21.5 [18.0-25.0] |
23.5 [19.7-27.3] |
23.9 [20.5-27.4] |
21.1 [17.7-24.4] |
25.5 [21.9-29.1] |
15-24 | 4.1 [2.8-5.4] |
||||||||||
25+ | 27.9 [25.9-29.9] |
29.6 [25.1-34.1] |
37.3 [33.1-41.5] |
32.6 [27.6-37.7] |
31.9 [27.1-36.6] |
32.9 [28.6-37.3] |
24.9 [20.7-29.0] |
27.2 [22.7-31.7] |
27.5 [23.5-31.5] |
24.0 [20.0-28.0] |
29.2 [25.0-33.4] |
Never smokers | |||||||||||
Total | 59.8 [58.3-61.3] |
51.5 [48.3-54.7] |
54.6 [51.7-57.6] |
49.9 [46.6-53.3] |
54.0 [50.4-57.5] |
55.1 [52.0-58.2] |
62.7 [59.5-65.9] |
59.9 [56.7-63.1] |
57.4 [54.4-60.4] |
61.1 [58.0-64.1] |
63.0 [59.8-66.1] |
15-19 | 88.8 [86.6-91.0] |
87.6 [82.4-92.8] |
84.9 [80.0-89.8] |
92.0 [88.5-95.5] |
91.2 [85.9-96.5] |
85.5 [80.2-90.8] |
89.7 [85.3-94.1] |
85.7 [81.4-90.0] |
84.5 [79.6-89.4] |
88.9 [84.4-93.4] |
92.2 [88.5-95.9] |
20-24 | 74.2 [71.2-77.3] |
68.4 [60.7-76.2] |
73.6 [67.6-79.7] |
74.7 [68.9-80.5] |
68.2 [59.7-76.6] |
72.0 [66.0-78.0] |
75.7 [69.6-81.8] |
72.2 [66.2-78.2] |
67.0 [59.8-74.2] |
71.4 [65.4-77.4] |
79.9 [74.4-85.3] |
25-44 | 64.9 [62.0-67.9] |
61.2 [54.5-67.9] |
63.0 [56.3-69.7] |
51.4 [43.7-59.2] |
63.3 [56.2-70.3] |
62.3 [56.5-68.1] |
64.8 [58.4-71.3] |
64.1 [57.6-70.5] |
67.0 [61.7-72.2] |
68.4 [63.0-73.8] |
69.1 [63.2-75.1] |
45+ | 50.4 [48.3-52.5] |
40.9 [36.8-45.0] |
44.1 [40.0-48.1] |
40.9 [36.7-45.1] |
43.4 [38.5-48.2] |
44.9 [40.4-49.3] |
55.5 [51.0-60.0] |
50.7 [46.2-55.2] |
44.7 [40.2-49.2] |
48.3 [43.5-53.2] |
53.0 [48.5-57.5] |
Male (15+) | 54.2 [52.0-56.5] |
43.0 [38.4-47.6] |
51.7 [46.9-56.5] |
42.8 [37.8-47.9] |
48.1 [42.6-53.6] |
50.1 [45.5-54.7] |
56.1 [51.2-60.9] |
54.5 [49.7-59.2] |
53.6 [49.2-58.1] |
55.9 [51.3-60.6] |
59.5 [54.5-64.6] |
15-24 | 77.7 [74.6-80.7] |
70.8 [63.7-77.8] |
73.1 [67.1-79.1] |
76.4 [70.6-82.1] |
73.0 [65.0-81.0] |
76.9 [70.9-82.9] |
78.0 [71.7-84.4] |
77.2 [72.0-82.4] |
71.0 [63.6-78.4] |
75.4 [70.0-80.8] |
83.3 [78.3-88.2] |
25+ | 49.8 [47.2-52.5] |
38.7 [33.5-44.0] |
47.6 [42.0-53.2] |
36.9 [31.0-42.8] |
43.9 [37.6-50.1] |
45.6 [40.4-50.8] |
51.7 [46.0-57.3] |
49.6 [43.9-55.3] |
50.0 [44.9-55.1] |
52.2 [46.7-57.7] |
55.0 [49.2-60.9] |
Female (15+) | 65.2 [63.2-67.2] |
59.7 [55.2-64.3] |
57.4 [53.4-61.4] |
56.6 [52.2-61.1] |
59.7 [55.0-64.4] |
60.0 [55.8-64.2] |
69.0 [64.8-73.2] |
65.2 [61.0-69.5] |
61.3 [57.5-65.1] |
66.4 [62.6-70.1] |
66.3 [62.4-70.3] |
15-24 | 84.3 [81.9-86.8] |
84.8 [78.6-91.1] |
85.4 [80.2-90.7] |
89.4 [85.4-93.4] |
85.9 [80.4-91.3] |
79.2 [73.7-85.1] |
86.5 [81.9-91.1] |
80.3 [74.5-86.0] |
79.9 [74.5-85.3] |
83.6 [77.7-89.4] |
88.0 [83.6-92.4] |
25+ | 61.9 [59.6-64.2] |
56.2 [51.2-61.2] |
52.7 [48.2-57.3] |
51.5 [46.4-56.6] |
55.8 [50.4-61.1] |
57.0 [52.2-61.6] |
65.9 [61.1-70.8] |
62.3 [57.3-67.2] |
57.8 [53.4-62.1] |
63.2 [58.8-67.6] |
62.7 [58.2-67.3] |
Average cigarettes smoked per dayTable 2 Footnote 1 | |||||||||||
Total | 13.8 [12.9-14.6] |
14.0 [12.8-15.3] |
14.7 [12.0-17.4] |
12.9 [11.3-14.5] |
15.5 [13.8-17.1] |
14.3 [12.6-15.9] |
13.2 [11.3-15.0] |
10.9 [9.5-12.3] |
13.3 [11.8-14.7] |
14.7 [13.0-16.3] |
14.8 [12.6-17.0] |
15-19 | 11.6 [9.2-14.1] |
||||||||||
20-24 | 11.8 [10.3-13.4] |
15.8 [12.5-19.1] |
14.9 [11.7-18.0] |
9.7 [7.1-12.3] |
14.1 [11.3-17.0] |
11.8 [9.8-13.8] |
|||||
25-44 | 13.1 [11.5-14.6] |
13.3 [11.1-15.6] |
11.4 [9.1-13.8] |
11.2 [8.3-14.0] |
15.2 [11.9-18.5] |
12.4 [10.3-14.5] |
12.4 [10.1-14.8] |
14.0 [10.6-17.4] |
|||
45+ | 14.8 [13.6-15.9] |
14.3 [12.5-16.0] |
17.9 [13.5-22.3] |
14.1 [12.0-16.2] |
15.6 [13.4-17.8] |
15.8 [13.3-18.4] |
13.3 [10.9-15.6] |
12.5 [10.9-14.1] |
14.0 [11.6-16.4] |
15.6 [13.8-17.4] |
16.4 [12.9-20.0] |
Male (15+) | 15.2 [14.0-16.3] |
16.0 [14.1-17.8] |
17.3 [13.1-21.5] |
13.3 [10.6-15.9] |
16.0 [13.7-18.4] |
14.7 [12.6-16.8] |
15.7 [13.0-18.4] |
11.6 [9.6-13.6] |
15.0 [12.6-17.4] |
15.3 [12.9-17.7] |
16.7 [13.4-20.0] |
15-24 | 11.9 [10.2-13.5] |
15.5 [12.4-18.6] |
|||||||||
25+ | 15.6 [14.3-16.9] |
16.0 [14.0-18.1] |
18.4 [13.6-23.1] |
13.1 [10.1-16.0] |
16.0 [13.3-18.6] |
14.9 [12.6-17.2] |
16.8 [13.8-19.8] |
11.7 [9.6-13.8] |
15.2 [12.4-17.9] |
15.5 [12.9-18.1] |
17.7 [14.1-21.4] |
Female (15+) | 11.9 [10.7-13.1] |
10.7 [9.3-12.2] |
11.1 [9.6-12.6] |
12.4 [10.8-14.1] |
14.8 [12.4-17.2] |
13.4 [10.6-16.1] |
10.5 [8.3-12.6] |
9.7 [7.9-11.5] |
11.4 [9.9-12.8] |
13.7 [11.6-15.9] |
12.0 [9.9-14.0] |
15-24 | 11.6 [9.3-13.9] |
||||||||||
25+ | 11.9 [10.6-13.2] |
10.7 [9.2-12.2] |
11.0 [9.4-12.6] |
12.5 [10.7-14.2] |
15.0 [12.4-17.5] |
13.7 [10.7-16.7] |
10.1 [7.8-12.4] |
10.2 [8.0-12.3] |
11.4 [9.9-12.9] |
14.0 [11.7-16.3] |
12.2 [10.0-14.4] |
How soon after waking do you have your first cigarette? | ||||||
---|---|---|---|---|---|---|
Sex | Age group (years) |
Population estimate ('000) |
Within 5 minutes (%) |
6-30 minutes (%) |
31-60 minutes (%) |
>60 minutes (%) |
Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2015. [95% confidence intervals in brackets] Table 3 Footnotes
|
||||||
Total | All age groups | 2,744 | 19.6 [15.5-23.8] |
35.8 [31.1-40.4] |
18.3 [14.3-22.3] |
26.3 [21.5-31.0] |
Male | 1,565 | 19.4 [13.5-25.2] |
37.0 [30.4-43.6] |
18.9 [13.9-23.9] |
24.7 [18.7-30.7] |
|
Female | 1,179 | 20.0 [14.2-25.8] |
34.1 [27.7-40.5] |
17.5 [11.4-23.7] |
28.3 [21.0-35.6] |
|
Both sexes | 15-19 | 84 | 40.7 [22.7-58.7] |
|||
20-24 | 240 | 17.8 [8.6-27.0] |
27.7 [18.0-37.4] |
19.0 [11.4-26.7] |
35.5 [25.3-45.7] |
|
25+ | 2,420 | 20.1 [15.5-24.7] |
37.0 [31.8-42.3] |
18.0 [13.5-22.5] |
24.9 [19.7-30.0] |
|
25-44 | 1,018 | 17.1 [9.0-25.1] |
36.7 [27.0-46.3] |
16.0 [9.8-22.2] |
30.3 [21.3-39.2] |
|
45+ | 1,402 | 22.3 [16.9-27.8] |
37.3 [31.4-43.2] |
19.4 [13.7-25.2] |
20.9 [15.3-26.5] |
|
Male | 15-19 | 51 | ||||
20-24 | 140 | 15.6 [6.4-24.7] |
34.3 [20.5-48.2] |
17.5 [9.4-25.5] |
32.6 [19.8-45.4] |
|
25+ | 1,374 | 20.1 [13.5-26.7] |
38.0 [30.6-45.3] |
18.7 [13.1-24.3] |
23.2 [16.6-29.8] |
|
25-44 | 649 | 19.0 [7.3-30.6] |
36.2 [23.2-49.3] |
19.8 [10.8-28.8] |
25.0 [14.0-36.0] |
|
45+ | 725 | 21.1 [13.9-28.3] |
39.6 [31.4-47.8] |
17.7 [11.4-24.1] |
21.6 [14.0-29.2] |
|
Female | 15-19 | 33 | ||||
20-24 | 101 | 39.5 [22.5-56.4] |
||||
25+ | 1,046 | 20.1 [13.9-26.4] |
35.8 [28.7-43.0] |
17.1 [10.2-23.9] |
27.0 [19.1-34.9] |
|
25-44 | 369 | 13.8 [5.7-21.8] |
37.4 [23.2-51.6] |
9.3 [4.0-14.6] |
39.5 [24.0-55.0] |
|
45+ | 677 | 23.6 [15.3-32.0] |
34.9 [27.1-42.8] |
21.3 [11.7-30.9] |
20.2 [12.6-27.7] |
Sex | Age group (years) |
Population estimate ('000) |
No attempts (%) |
1 attempt (%) |
2-3 attempts (%) |
4 or more attempts (%) |
---|---|---|---|---|---|---|
Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2015. [95% confidence intervals in brackets] Table 4 Footnotes
|
||||||
Total | All age groups | 2,708 | 50.3 [45.1-55.5] |
16.6 [12.4-20.8] |
19.5 [15.4-23.6] |
13.6 [10.5-16.7] |
Male | 1,541 | 52.0 [44.8-59.3] |
14.6 [9.1-20.1] |
19.3 [14.0-24.6] |
14.1 [10.0-18.2] |
|
Female | 1,167 | 48.0 [40.9-55.1] |
19.1 [13.1-25.2] |
19.9 [13.7-26.0] |
13.0 [8.5-17.5] |
|
Both sexes |
15-17 | 33 | ||||
18-19 | 54 | |||||
15-19 | 87 | 29.4 [14.9-43.8] |
28.1 [11.9-44.3] |
28.8 [12.5-45.1] |
||
20-22 | 122 | 41.9 [28.5-55.4] |
20.4 [10.1-30.8] |
13.5 [6.1-21.0] |
24.1 [12.2-36.0] |
|
23-24 | 117 | 36.2 [19.2-53.2] |
25.3 [11.1-39.5] |
|||
20-24 | 238 | 39.1 [27.7-50.5] |
23.6 [13.2-34.0] |
19.3 [11.5-27.1] |
18.0 [10.7-25.3] |
|
25-34 | 455 | 45.2 [30.0-60.3] |
25.3 [12.9-37.6] |
|||
35-44 | 537 | 53.6 [41.5-65.7] |
14.8 [6.0-23.6] |
17.7 [8.9-26.5] |
||
45-54 | 493 | 48.9 [38.1-59.6] |
21.7 [11.9-31.5] |
17.5 [8.7-26.3] |
11.9 [4.5-19.4] |
|
55+ | 898 | 56.7 [48.4-65.0] |
14.5 [7.5-21.5] |
18.0 [10.8-25.3] |
10.7 [6.6-14.8] |
|
25+ | 2,383 | 52.2 [46.5-57.9] |
16.0 [11.4-20.5] |
19.2 [14.7-23.7] |
12.6 [9.2-16.1] |
|
Male | 15-19 | 54 | ||||
20-24 | 139 | 32.8 [20.5-45.2] |
25.2 [11.7-38.7] |
20.7 [10.1-31.2] |
21.3 [10.4-32.2] |
|
25-44 | 624 | 50.1 [37.1-63.0] |
23.7 [13.4-34.1] |
|||
45+ | 724 | 59.3 [49.9-68.7] |
14.7 [6.8-22.7] |
14.7 [9.1-20.4] |
11.2 [6.4-16.0] |
|
Female | 15-19 | 33 | ||||
20-24 | 99 | 48.0 [29.2-66.7] |
||||
25-44 | 368 | 49.2 [34.7-63.7] |
16.8 [7.5-26.1] |
|||
45+ | 667 | 48.1 [38.9-57.3] |
19.6 [11.8-27.3] |
21.2 [11.8-30.7] |
11.1 [5.5-16.7] |
Sex | Age group (years) |
Population estimate ('000) |
Total quitters (%) |
Short term quittersTable 5 Footnote 1 (%) |
Long term quittersTable 5 Footnote 2 (%) |
---|---|---|---|---|---|
Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2015. [95% confidence intervals in brackets] Table 5 Footnotes
|
|||||
Total | All age groups | 11,931 | 67.2 [64.9-69.5] |
3.7 [2.7-4.7] |
63.5 [61.1-65.8] |
Male | 6,699 | 65.2 [61.9-68.4] |
2.8 [1.7-4.0] |
62.3 [59.0-65.7] |
|
Female | 5,232 | 69.8 [66.7-72.8] |
4.9 [3.1-6.6] |
64.9 [61.7-68.1] |
|
Both sexes |
15-24 | 864 | 24.4 [19.0-29.8] |
9.7 [6.0-13.4] |
14.7 [10.3-19.1] |
15-19 | 234 | ||||
20-24 | 631 | 28.3 [21.9-34.6] |
9.4 [5.5-13.2] |
18.9 [13.1-24.7] |
|
25+ | 11,067 | 70.5 [68.1-72.9] |
3.2 [2.2-4.3] |
67.3 [64.8-69.8] |
|
25-44 | 3,385 | 56.2 [51.0-61.3] |
4.8 [2.6-7.0] |
51.4 [46.1-56.6] |
|
45+ | 7,681 | 76.8 [74.4-79.3] |
2.6 [1.4-3.7] |
74.3 [71.7-76.9] |
|
Male | 15-24 | 519 | 23.3 [15.9-30.6] |
10.1 [4.6-15.7] |
13.2 [7.6-18.7] |
15-19 | 140 | ||||
20-24 | 379 | 25.8 [17.3-34.2] |
8.9 [3.7-14.1] |
16.9 [9.4-24.3] |
|
25+ | 6,180 | 68.7 [65.3-72.1] |
2.2 [1.1-3.3] |
66.5 [63.0-70.0] |
|
25-44 | 1,947 | 49.9 [42.5-57.3] |
2.7 [1.4-3.9] |
47.2 [39.8-54.6] |
|
45+ | 4,233 | 77.3 [74.0-80.7] |
75.3 [71.7-79.0] |
||
Female | 15-24 | 345 | 26.1 [18.3-33.9] |
9.0 [4.8-13.2] |
17.1 [10.0-24.2] |
15-19 | 94 | ||||
20-24 | 252 | 32.1 [22.1-42.1] |
10.1 [4.8-15.3] |
22.0 [12.7-31.3] |
|
25+ | 4,886 | 72.9 [69.7-76.0] |
4.6 [2.7-6.4] |
68.3 [64.9-71.7] |
|
25-44 | 1,438 | 64.7 [58.1-71.4] |
57.0 [49.7-64.4] |
||
45+ | 3,448 | 76.2 [72.7-79.8] |
3.3 [1.5-5.0] |
73.0 [69.3-76.6] |
Sex | Age group (years) |
Population estimate ('000) |
Precontemplation (%) |
Contemplation (%) |
Preparation (%) |
Action (%) |
Maintenance (%) |
---|---|---|---|---|---|---|---|
Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2015. [95% confidence intervals in brackets] The first 3 categories apply to current smokers, last 2 categories apply to former smokers. Table 6 Footnotes
|
|||||||
Total | All age groups | 11,931 | 12.0 [10.4-13.6] |
13.2 [11.4-15.0] |
6.1 [5.1-7.2] |
1.6 [1.0-2.2] |
67.1 [64.8-69.4] |
Male | 6,699 | 12.3 [10.0-14.6] |
14.2 [11.8-16.6] |
6.4 [5.0-7.8] |
65.7 [62.4-69.1] |
||
Female | 5,232 | 11.5 [9.5-13.5] |
12.0 [9.5-14.5] |
5.8 [4.2-7.5] |
1.9 [1.0-2.8] |
68.8 [65.8-71.8] |
|
Both sexes |
15-19 | 234 | 35.0 [25.6-44.4] |
24.4 [15.8-33.0] |
19.4 [10.5-28.2] |
19.5 [9.6-29.4] |
|
20-24 | 631 | 27.5 [21.7-33.4] |
22.1 [17.0-27.1] |
17.7 [12.5-22.9] |
4.1 [1.7-6.5] |
28.6 [21.8-35.3] |
|
25-44 | 3,385 | 14.6 [10.6-18.6] |
17.6 [13.4-21.8] |
9.1 [6.3-11.9] |
57.2 [51.9-62.5] |
||
45+ | 7,681 | 8.9 [7.3-10.4] |
10.2 [8.3-12.1] |
3.5 [2.5-4.5] |
1.4 [0.6-2.3] |
76.0 [73.5-78.5] |
|
Male | 15-19 | 140 | 29.0 [17.9-40.0] |
25.7 [14.6-36.8] |
26.2 [12.9-39.5] |
||
20-24 | 379 | 25.8 [18.5-33.1] |
23.0 [16.4-29.6] |
20.2 [12.8-27.6] |
26.4 [17.5-35.2] |
||
25-44 | 1,947 | 18.2 [12.1-24.3] |
19.9 [13.7-26.0] |
8.1 [4.6-11.6] |
52.9 [45.0-60.7] |
||
45+ | 4,233 | 7.9 [5.9-9.9] |
10.4 [7.8-12.9] |
3.7 [2.2-5.3] |
76.7 [73.2-80.3] |
||
Female | 15-19 | 94 | 44.0 [28.4-59.6] |
22.4 [8.6-36.3] |
|||
20-24 | 252 | 30.2 [19.9-40.4] |
20.7 [12.4-29.0] |
13.9 [7.6-20.2] |
31.9 [21.2-42.6] |
||
25-44 | 1,438 | 9.7 [5.4-13.9] |
14.6 [9.7-19.5] |
10.5 [5.8-15.2] |
63.1 [56.4-69.7] |
||
45+ | 3,448 | 10.0 [7.5-12.5] |
10.0 [7.1-12.9] |
3.2 [1.8-4.5] |
75.1 [71.6-78.7] |
Province | % Children Age 0-11 regularly exposed |
% Children Age 12-17 regularly exposed |
% Children Age 0-17 regularly exposed |
---|---|---|---|
Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2015. [95% confidence intervals in brackets] Table 7 Footnotes
|
|||
Canada | 1.8 [1.3-2.3] |
4.8 [3.9-5.7] |
2.9 [2.4-3.4] |
Newfoundland and Labrador | 2.3 [1.3-3.2] |
||
Prince Edward Island | |||
Nova Scotia | 4.4 [3.0-5.9] |
||
New Brunswick | |||
Quebec | 4.2 [2.7-5.8] |
9.4 [6.5-12.2] |
5.9 [4.4-7.5] |
Ontario | |||
Manitoba | 6.2 [3.9-8.5] |
3.4 [2.2-4.6] |
|
Saskatchewan | 7.5 [4.9-10.1] |
4.6 [3.2-6.0] |
|
Alberta | 2.3 [1.4-3.1] |
||
British Columbia | N/R |
Sex | Age group (years) |
CigarettesTable 8 Footnote 1 (%) |
Any Tobacco ProductTable 8 Footnote 2 (%) |
E-Cigarettes (%) |
---|---|---|---|---|
Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2015. [95% confidence intervals in brackets] Table 8 Footnotes
|
||||
Total | All age groups | 13.2 [12.1-14.2] |
15.5 [14.4-16.6] |
3.2 [2.7-3.7] |
Male | 15.8 [14.1-17.5] |
19.5 [17.7-21.4] |
3.6 [2.8-4.4] |
|
Female | 10.6 [9.3-11.8] |
11.6 [10.2-12.9] |
2.8 [2.1-3.5] |
|
Both sexes | 15-19 | 9.8 [7.8-11.9] |
13.1 [10.7-15.5] |
6.3 [4.6-7.9] |
20-24 | 18.9 [16.2-21.6] |
23.8 [20.9-26.6] |
6.3 [4.9-7.8] |
|
25+ | 12.9 [11.7-14.1] |
14.9 [13.6-16.1] |
2.6 [2.0-3.2] |
|
25-44 | 15.3 [13.0-17.6] |
17.8 [15.4-20.2] |
3.4 [2.5-4.4] |
|
45+ | 11.4 [10.1-12.7] |
13.0 [11.7-14.4] |
2.1 [1.4-2.8] |
|
Male | 15-19 | 11.7 [8.6-14.8] |
16.1 [12.6-19.6] |
8.5 [5.8-11.1] |
20-24 | 23.9 [19.5-28.3] |
30.9 [26.3-35.6] |
8.5 [6.1-11.0] |
|
25+ | 15.4 [13.4-17.3] |
18.7 [16.6-20.8] |
2.7 [1.8-3.5] |
|
25-44 | 20.2 [16.3-24.0] |
24.1 [20.0-28.2] |
3.4 [2.0-4.8] |
|
45+ | 12.3 [10.4-14.2] |
15.2 [13.0-17.3] |
2.2 [1.2-3.2] |
|
Female | 15-19 | 7.9 [5.3-10.5] |
10.0 [7.0-13.0] |
4.0 [2.2-5.8] |
20-24 | 13.6 [10.2-17.1] |
16.3 [12.6-19.9] |
4.0 [2.4-5.7] |
|
25+ | 10.5 [9.1-11.9] |
11.2 [9.7-12.7] |
2.6 [1.8-3.4] |
|
25-44 | 10.4 [8.0-12.8] |
11.6 [9.1-14.1] |
3.5 [2.0-5.0] |
|
45+ | 10.5 [8.8-12.3] |
11.0 [9.3-12.8] |
2.1 [1.1-3.0] |
Sex | Age group (years) |
Ever tried (%) |
DailyTable 9 Footnote 1 (%) |
OccasionalTable 9 Footnote 1 (%) |
---|---|---|---|---|
Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2015. [95% confidence intervals in brackets] Table 9 Footnotes
|
||||
Total | All age groups | 13.2 [12.3-14.2] |
0.8 [0.5-1.1] |
2.1 [1.7-2.5] |
Male | 16.1 [14.5-17.7] |
1.0 [0.5-1.4] |
2.3 [1.7-2.9] |
|
Female | 10.5 [9.4-11.6] |
0.6 [0.3-1.0] |
1.9 [1.4-2.5] |
|
Both sexes |
15-19 | 25.7 [22.8-28.6] |
5.0 [3.6-6.5] |
|
20-24 | 30.5 [27.3-33.7] |
1.8 [0.8-2.7] |
5.0 [3.6-6.5] |
|
25+ | 10.5 [9.4-11.6] |
0.8 [0.4-1.1] |
1.6 [1.1-2.0] |
|
25-44 | 14.8 [12.8-16.8] |
0.9 [0.3-1.4] |
2.0 [1.2-2.7] |
|
45+ | 7.9 [6.7-9.0] |
0.7 [0.3-1.1] |
1.3 [0.8-1.8] |
|
Male | 15-19 | 32.4 [28.0-36.8] |
6.6 [4.4-8.9] |
|
20-24 | 37.6 [32.3-42.8] |
2.9 [1.2-4.7] |
5.5 [3.3-7.8] |
|
25+ | 12.5 [10.7-14.2] |
0.8 [0.3-1.4] |
1.6 [1.0-2.2] |
|
25-44 | 18.4 [14.9-21.9] |
1.8 [0.9-2.7] |
||
45+ | 8.7 [6.8-10.5] |
1.5 [0.7-2.2] |
||
Female | 15-19 | 18.6 [14.8-22.4] |
3.4 [1.6-5.1] |
|
20-24 | 23.1 [19.3-27.0] |
4.5 [2.6-6.5] |
||
25+ | 8.7 [7.5-9.9] |
0.7 [0.3-1.1] |
1.6 [1.0-2.2] |
|
25-44 | 11.3 [9.1-13.4] |
2.2 [1.0-3.3] |
||
45+ | 7.1 [5.6-8.6] |
1.2 [0.5-1.9] |
Sex | Age group (years) |
Any tobacco productTable 10 Footnote 1 (%) |
CigarettesTable 10 Footnote 2 (%) |
Cigars (%) |
Little cigars or cigarillos (%) |
Pipe (%) |
Smokeless tobacco (%) |
Water-pipe w. tobacco (%) |
E-Cigarettes (%) |
---|---|---|---|---|---|---|---|---|---|
Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2015. [95% confidence intervals in brackets] Table 10 Footnotes
|
|||||||||
Total | All age groups | 15.5 [14.4-16.6] |
13.2 [12.1-14.2] |
1.2 [0.9-1.5] |
1.8 [1.4-2.1] |
0.5 [0.3-0.7] |
0.4 [0.3-0.5] |
0.5 [0.3-0.7] |
3.2 [2.7-3.7] |
Male | 19.5 [17.7-21.4] |
15.8 [14.1-17.5] |
2.2 [1.5-2.8] |
2.7 [2.1-3.2] |
0.8 [0.5-1.0] |
0.8 [0.5-1.0] |
0.7 [0.4-0.9] |
3.6 [2.8-4.4] |
|
Female | 11.6 [10.2-12.9] |
10.6 [9.3-11.8] |
0.9 [0.6-1.2] |
0.3 [0.1-0.4] |
0.4 [0.2-0.6] |
2.8 [2.1-3.5] |
|||
Both sexes | 15-19 | 13.1 [10.7-15.5] |
9.8 [7.8-11.9] |
1.3 [0.5-2.0] |
3.0 [2.0-4.1] |
0.9 [0.3-1.4] |
1.7 [0.9-2.6] |
6.3 [4.6-7.9] |
|
20-24 | 23.8 [20.9-26.6] |
18.9 [16.2-21.6] |
2.3 [1.3-3.3] |
5.7 [4.2-7.2] |
1.5 [0.6-2.3] |
1.8 [1.1-2.6] |
2.7 [1.6-3.7] |
6.3 [4.9-7.8] |
|
25+ | 14.9 [13.6-16.1] |
12.9 [11.7-14.1] |
1.1 [0.7-1.4] |
1.3 [0.9-1.6] |
0.4 [0.2-0.5] |
0.2 [0.1-0.3] |
2.6 [2.0-3.2] |
||
25-44 | 17.8 [15.4-20.2] |
15.3 [13.0-17.6] |
1.1 [0.6-1.7] |
1.7 [1.0-2.3] |
3.4 [2.5-4.4] |
||||
45+ | 13.0 [11.7-14.4] |
11.4 [10.1-12.7] |
1.0 [0.6-1.5] |
1.0 [0.6-1.4] |
2.1 [1.4-2.8] |
Drug Category | Overall | Males | Females | 15-19 | 20-24 | 25+ |
---|---|---|---|---|---|---|
Source: Canadian Tobacco Alcohol and Drugs Survey, February - December 2015 [95% confidence intervals in brackets] Table 11 Footnotes
|
||||||
Sample size | 15,154 | 7,001 | 8,153 | 2,645 | 2,550 | 9,959 |
Cannabis use | ||||||
Cannabis - lifetime | 44.5 [43.0-46.1] |
52.1 [49.7-54.4] |
37.2 [35.1-39.3] |
28.9 [25.7-32.1] |
53.7 [50.0-57.3] |
44.9 [43.2-46.7] |
Cannabis - past year | 12.3 [11.3-13.3] |
14.9 [13.4-16.5] |
9.7 [8.5-10.9] |
20.6 [17.8-23.5] |
29.7 [26.4-33.0] |
9.9 [8.9-11.0] |
Median age of initiation (years) | 17.0 [16.7-17.3] |
17.0 [16.7-17.3] |
17.0 [16.7-17.3] |
16.0 [15.7-16.3] |
16.0 [15.7-16.3] |
18.0 [17.7-18.3] |
Mean age of initiation (years) | 18.4 [18.1-18.7] |
18.4 [18.0-18.8] |
18.4 [18.0-18.7] |
15.4 [15.2-15.6] |
16.5 [16.2-16.8] |
18.8 [18.4-19.1] |
Illicit drug use past year | ||||||
Cocaine/Crack | 1.2 [0.9-1.5] |
1.5 [1.1-1.9] |
0.9 [0.5-1.3] |
2.1 [1.2-3.0] |
4.7 [3.2-6.2] |
0.8 [0.5-1.1] |
Speed/Methamphetamine/Crystal meth | 0.2 [0.1-0.3] |
|||||
Hallucinogens | 1.2 [0.8-1.5] |
1.8 [1.1-2.5] |
0.6 [0.2-0.9] |
2.6 [1.2-3.9] |
2.8 [1.8-3.8] |
0.9 [0.4-1.3] |
Hallucinogens (including salvia) | 1.2 [0.8-1.6] |
1.8 [1.1-2.5] |
0.6 [0.3-0.9] |
2.9 [1.5-4.3] |
3.0 [2.0-4.1] |
0.9 [0.5-1.3] |
Ecstasy | 0.7 [0.5-0.9] |
1.0 [0.6-1.3] |
0.5 [0.3-0.7] |
2.3 [1.2-3.4] |
4.4 [2.7-6.0] |
|
Salvia | ||||||
Heroin | ||||||
Any of 6 drugs (hallucinogens excl. salvia)Table 11 Footnote 1 | 12.6 [11.6-13.6] |
15.2 [13.7-16.8] |
10.0 [8.8-11.2] |
21.0 [18.1-23.9] |
30.8 [27.5-34.0] |
10.1 [9.1-11.2] |
Any of 5 drugs (hallucinogens excl. salvia)Table 11 Footnote 2 | 2.3 [1.9-2.8] |
3.2 [2.4-4.0] |
1.5 [1.0-1.9] |
5.0 [3.4-6.6] |
8.8 [6.7-10.8] |
1.5 [1.0-2.0] |
Any of 6 drugs (hallucinogens incl. salvia)Table 11 Footnote 1 | 12.6 [11.6-13.6] |
15.2 [13.7-16.8] |
10.0 [8.8-11.2] |
21.1 [18.2-24.0] |
30.8 [27.5-34.0] |
10.1 [9.1-11.2] |
Any of 5 drugs (hallucinogens incl. salvia)Table 11 Footnote 2 | 2.3 [1.9-2.8] |
3.2 [2.4-4.1] |
1.5 [1.0-1.9] |
5.1 [3.5-6.8] |
9.0 [6.9-11.1] |
1.5 [1.0-2.0] |
Any drugTable 11 Footnote 3 | 13.0 [11.9-14.0] |
15.6 [14.1-17.2] |
10.3 [9.1-11.6] |
21.6 [18.7-24.6] |
31.3 [28.0-34.6] |
10.4 [9.4-11.5] |
Lifetime illicit drug use | ||||||
Cocaine/Crack | 8.3 [7.4-9.2] |
10.7 [9.2-12.2] |
5.9 [4.9-6.9] |
2.9 [1.8-3.9] |
10.3 [8.1-12.4] |
8.5 [7.5-9.5] |
Speed/Methamphetamine/Crystal meth | 2.7 [2.3-3.2] |
3.0 [2.2-3.7] |
2.5 [2.0-3.1] |
1.9 [1.1-2.8] |
5.0 [3.5-6.6] |
2.6 [2.1-3.1] |
Hallucinogens | 12.2 [11.2-13.3] |
15.6 [13.9-17.4] |
8.9 [7.7-10.2] |
4.6 [3.0-6.3] |
12.7 [10.3-15.1] |
12.8 [11.6-14.1] |
Hallucinogens (including salvia) | 12.9 [11.8-13.9] |
16.6 [14.9-18.4] |
9.2 [7.9-10.5] |
5.7 [3.9-7.5] |
16.3 [13.6-19.0] |
13.1 [11.9-14.4] |
Ecstasy | 6.2 [5.4-6.9] |
7.7 [6.5-9.0] |
4.6 [3.8-5.5] |
4.1 [2.8-5.3] |
14.7 [12.1-17.2] |
5.5 [4.7-6.4] |
Salvia | 2.2 [1.7-2.7] |
3.4 [2.6-4.3] |
1.0 [0.7-1.3] |
2.7 [1.6-3.7] |
8.6 [6.6-10.5] |
1.6 [1.0-2.1] |
Heroin | 0.4 [0.2-0.6] |
0.6 [0.3-0.8] |
0.4 [0.2-0.6] |
|||
Any of 6 drugs (hallucinogens excl. salvia)Table 11 Footnote 1 | 45.0 [43.4-46.6] |
52.4 [50.0-54.7] |
37.9 [35.8-39.9] |
29.0 [25.8-32.3] |
54.0 [50.4-57.6] |
45.4 [43.7-47.2] |
Any of 5 drugs (hallucinogens excl. salvia)Table 11 Footnote 2 | 16.3 [15.1-17.4] |
20.2 [18.3-22.0] |
12.5 [11.1-13.9] |
7.4 [5.5-9.3] |
21.6 [18.6-24.5] |
16.5 [15.2-17.8] |
Any of 6 drugs (hallucinogens incl. salvia)Table 11 Footnote 1 | 45.1 [43.5-46.6] |
52.4 [50.1-54.8] |
37.9 [35.8-40.0] |
29.0 [25.8-32.3] |
54.3 [50.7-57.9] |
45.5 [43.7-47.3] |
Any of 5 drugs (hallucinogens incl. salvia)Table 11 Footnote 2 | 16.6 [15.4-17.8] |
20.7 [18.8-22.6] |
12.6 [11.2-14.0] |
8.0 [6.1-10.0] |
23.1 [20.0-26.1] |
16.7 [15.4-18.0] |
Any drugTable 11 Footnote 3 | 45.8 [44.2-47.4] |
53.2 [50.8-55.5] |
38.6 [36.5-40.7] |
30.2 [26.8-33.5] |
55.3 [51.8-58.8] |
46.1 [44.4-47.9] |
Pharmaceutical Drug Category | Overall | Males | Females | 15-19 | 20-24 | 25+ |
---|---|---|---|---|---|---|
Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2015. [95% confidence intervals in brackets] Table 12 Footnotes
|
||||||
Sample size | 15,154 | 7,001 | 8,153 | 2,645 | 2,550 | 9,959 |
Pain Relievers | ||||||
Pain relievers | 13.1 [11.9-14.2] |
12.1 [10.4-13.9] |
13.9 [12.5-15.4] |
7.4 [5.8-9.1] |
12.8 [10.4-15.1] |
13.6 [12.2-14.9] |
Pain relievers to get high | 0.2 [0.1-0.3] |
0.3 [0.1-0.5] |
||||
Pain relievers to get high - among users | 1.7 [0.8-2.6] |
2.6 [0.9-4.2] |
||||
Abuse of pain relievers (includes to get high) | 0.3 [0.2-0.4] |
0.4 [0.2-0.6] |
||||
Abuse of pain relievers (includes to get high) - among users | 2.2 [1.2-3.2] |
3.1 [1.4-4.8] |
||||
Stimulants | ||||||
Stimulants | 1.1 [0.9-1.4] |
1.3 [0.9-1.7] |
1.0 [0.7-1.3] |
4.8 [3.3-6.3] |
4.2 [2.6-5.8] |
0.5 [0.3-0.8] |
Stimulants to get high | 0.2 [0.1-0.3] |
|||||
Stimulants to get high - among users | 13.7 [6.5-20.9] |
|||||
Abuse of stimulants (includes to get high) | 0.2 [0.1-0.3] |
0.3 [0.1-0.4] |
||||
Abuse of stimulants (includes to get high) - among users | 22.7 [13.6-31.8] |
23.6 [10.8-36.4] |
41.4 [21.4-61.4] |
|||
Sedatives | ||||||
Sedatives | 10.5 [9.6-11.4] |
7.3 [6.2-8.3] |
13.6 [12.1-15.1] |
4.6 [3.1-6.0] |
6.7 [5.0-8.3] |
11.4 [10.3-12.4] |
Sedatives to get high | 0.3 [0.1-0.4] |
|||||
Sedatives to get high - among users | 2.7 [1.3-4.1] |
|||||
Any Pharmaceutical | ||||||
Any pharmaceutical | 21.6 [20.2-22.9] |
18.3 [16.5-20.1] |
24.7 [22.8-26.6] |
15.2 [12.7-17.6] |
19.1 [16.3-21.9] |
22.3 [20.8-23.9] |
Any pharmaceutical to get high | 0.5 [0.3-0.6] |
0.5 [0.3-0.8] |
0.4 [0.2-0.6] |
1.3 [0.5-2.1] |
1.8 [0.7-3.0] |
0.3 [0.1-0.4] |
Any pharmaceutical to get high - among users | 2.2 [1.4-3.0] |
3.0 [1.5-4.5] |
1.6 [0.8-2.5] |
8.5 [3.5-13.6] |
9.7 [4.0-15.3] |
1.2 [0.5-1.9] |
Abuse of any pharmaceutical (includes to get high) | 0.6 [0.4-0.8] |
0.7 [0.4-1.0] |
0.5 [0.3-0.7] |
1.5 [0.7-2.4] |
2.7 [1.3-4.0] |
0.3 [0.2-0.5] |
Abuse of any pharmaceutical to get high - among users | 2.8 [1.9-3.7] |
3.9 [2.3-5.4] |
2.0 [1.1-3.0] |
10.7 [5.2-16.2] |
14.4 [7.8-20.9] |
1.4 [0.7-2.2] |
Drug related harms in past yearTable 13 Footnote 1 | Overall | Males | Females | 15-19 | 20-24 | 25+ |
---|---|---|---|---|---|---|
Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2015. [95% confidence intervals in brackets] Table 13 Footnotes
|
||||||
Sample size | 15,154 | 7,001 | 8,153 | 2,645 | 2,550 | 9,959 |
Any drug harm to self - total population | 2.8 [2.3-3.3] |
3.8 [2.9-4.6] |
1.9 [1.4-2.4] |
6.3 [4.6-7.9] |
8.1 [6.3-9.9] |
2.0 [1.5-2.6] |
Any drug harm to self among users of any 5 drugsTable 13 Footnote 2 | 31.8 [23.4-40.1] |
31.9 [21.2-42.5] |
31.6 [18.0-45.2] |
50.3 [33.3-67.3] |
40.0 [27.2-52.8] |
21.5 [9.9-33.0] |
Any drug harm to self among abusers of pharmaceuticalsTable 13 Footnote 3 | 43.5 [28.4-58.5] |
51.0 [30.8-71.1] |
34.2 [14.4-54.1] |
61.3 [37.9-84.8] |
||
Any drug harm to self among users/abusers of any drugsTable 13 Footnote 4 | 15.0 [12.5-17.6] |
17.9 [14.1-21.7] |
10.8 [7.9-13.7] |
25.4 [18.8-31.9] |
21.3 [16.2-26.3] |
11.4 [8.1-14.6] |
Drug Category / Indicator | Canada | NL | PE | NS | NB | QC | ON | MB | SK | AB | BC |
---|---|---|---|---|---|---|---|---|---|---|---|
Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2015. Table 14 Footnotes
|
|||||||||||
Sample size | 15,154 | 1,420 | 1,428 | 1,437 | 1,430 | 1,547 | 1,451 | 1,537 | 1,598 | 1,709 | 1,597 |
Cannabis use | |||||||||||
Cannabis - lifetime | 44.5 | 37.9 | 40.0 | 51.2 | 42.6 | 41.6 | 45.0 | 40.1 | 40.1 | 43.6 | 51.3 |
Cannabis - past year | 12.3 | 9.9 | 8.2 | 14.4 | 9.0 | 9.8 | 12.8 | 11.3 | 10.2 | 11.1 | 17.3 |
Illicit drug use past year | |||||||||||
Cocaine/Crack | 1.2 | 1.9 | 1.6 | 1.8 | |||||||
Speed/Methamphetamine/Crystal meth | 0.2 | ||||||||||
Hallucinogens | 1.2 | 1.4 | 3.1 | ||||||||
Ecstasy | 0.7 | 1.4 | |||||||||
Salvia | |||||||||||
Heroin | |||||||||||
Any of 6 drugs (hallucinogens excl. salvia)Table 14 Footnote 1 | 12.6 | 10.2 | 8.3 | 14.8 | 9.0 | 10.0 | 13.0 | 12.0 | 10.4 | 11.8 | 17.8 |
Any of 5 drugs (hallucinogens excl. salvia)Table 14 Footnote 2 | 2.3 | 1.9 | 1.6 | 1.9 | 2.1 | 2.7 | 3.1 | 4.4 | |||
Any drugTable 14 Footnote 3 | 13.0 | 10.4 | 8.5 | 15.3 | 9.4 | 10.3 | 13.3 | 12.2 | 10.8 | 12.4 | 18.3 |
Lifetime illicit drug use | |||||||||||
Cocaine/Crack | 8.3 | 5.1 | 4.5 | 6.8 | 5.7 | 7.9 | 6.8 | 7.4 | 7.7 | 10.1 | 13.1 |
Speed/Methamphetamine/Crystal meth | 2.7 | 2.4 | 5.3 | 1.9 | 2.4 | 2.1 | |||||
Hallucinogens | 12.2 | 7.6 | 8.5 | 12.1 | 8.8 | 9.9 | 11.9 | 11.6 | 11.7 | 13.1 | 17.9 |
Ecstasy | 6.2 | 3.7 | 3.7 | 5.2 | 2.8 | 5.8 | 5.4 | 4.1 | 5.3 | 7.8 | 9.5 |
Salvia | 2.2 | 2.5 | 2.1 | 2.1 | 3.7 | 2.2 | 2.4 | 2.5 | |||
Heroin | 0.4 | ||||||||||
Any of 6 drugs (hallucinogens excl. salvia)Table 14 Footnote 1 | 45.0 | 38.0 | 40.1 | 51.4 | 42.9 | 42.4 | 45.2 | 40.4 | 40.5 | 44.3 | 52.0 |
Any of 5 drugs (hallucinogens excl. salvia)Table 14 Footnote 2 | 16.3 | 9.9 | 10.5 | 14.7 | 10.6 | 15.7 | 15.0 | 14.8 | 13.8 | 17.9 | 22.7 |
Any drugTable 14 Footnote 3 | 45.8 | 38.4 | 40.5 | 51.8 | 43.2 | 43.2 | 46.0 | 41.1 | 41.1 | 45.1 | 52.7 |
Drug related harms in past yearTable 14 Footnote 4 | |||||||||||
Any drug harm to self - total populationTable 14 Footnote 5 | 2.8 | 2.2 | 2.7 | 2.1 | 3.0 | 2.1 | 3.8 | 3.1 | 3.4 | 4.1 |
Alcohol indicator | Overall | Males | Females | 15-19 | 20-24 | 25+ |
---|---|---|---|---|---|---|
Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2015. [95% confidence intervals in brackets] Table 15 Footnotes
|
||||||
Sample size | 15,154 | 7,001 | 8,153 | 2,645 | 2,550 | 9,959 |
Alcohol | ||||||
Lifetime use | 90.9 [90.0-91.7] |
94.2 [93.4-95.0] |
87.7 [86.2-89.2] |
66.4 [63.2-69.6] |
88.5 [85.9-91.1] |
93.2 [92.3-94.1] |
Past 12 month use | 76.9 [75.6-78.3] |
81.3 [79.4-83.1] |
72.7 [70.6-74.8] |
59.1 [55.5-62.6] |
82.7 [79.7-85.6] |
77.8 [76.3-79.4] |
Mean age of initiation (years) | 18.4 [18.3-18.6] |
17.6 [17.4-17.8] |
19.3 [19.1-19.6] |
15.8 [15.7-16.0] |
16.9 [16.7-17.0] |
18.7 [18.6-18.9] |
Exceeding low-risk drinking guidelines (LRDG)Footnote 1 | ||||||
Exceeds LRDG chronic | 15.2 [14.1-16.3] |
17.9 [16.0-19.7] |
12.7 [11.3-14.1] |
9.1 [7.3-10.8] |
22.9 [19.9-25.9] |
15.0 [13.7-16.3] |
Exceeds LRDG acute | 11.7 [10.7-12.7] |
14.3 [12.6-16.0] |
9.2 [7.9-10.5] |
6.6 [5.1-8.1] |
19.4 [16.5-22.2] |
11.4 [10.2-12.6] |
Exceeds LRDG chronic - among drinkers | 20.0 [18.5-21.4] |
22.2 [19.9-24.5] |
17.6 [15.7-19.5] |
15.5 [12.7-18.4] |
27.8 [24.3-31.3] |
19.4 [17.7-21.1] |
Exceeds LRDG acute - among drinkers | 15.4 [14.0-16.7] |
17.8 [15.7-19.9] |
12.8 [11.1-14.5] |
11.3 [8.9-13.8] |
23.5 [20.2-26.9] |
14.8 [13.2-16.3] |
Alcohol indicator | Canada | NL | PE | NS | NB | QC | ON | MB | SK | AB | BC |
---|---|---|---|---|---|---|---|---|---|---|---|
Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2015. Table 16 Footnotes
|
|||||||||||
Sample size | 15,154 | 1,420 | 1,428 | 1,437 | 1,430 | 1,547 | 1,451 | 1,537 | 1,598 | 1,709 | 1,597 |
Alcohol | |||||||||||
Lifetime use | 90.9 | 91.2 | 91.2 | 91.2 | 91.8 | 93.9 | 89.1 | 88.9 | 90.4 | 89.7 | 92.3 |
Past 12 month use | 76.9 | 73.7 | 73.0 | 75.8 | 75.1 | 82.1 | 73.6 | 75.1 | 75.2 | 77.2 | 79.0 |
Exceeding low-risk drinking guidelines (LRDG)Table 16 Footnote 1 | |||||||||||
Exceeds LRDG chronic | 15.2 | 20.3 | 14.0 | 17.0 | 14.3 | 15.8 | 14.6 | 16.0 | 16.4 | 12.9 | 16.7 |
Exceeds LRDG acute | 11.7 | 15.7 | 10.0 | 13.4 | 9.8 | 11.0 | 11.8 | 12.5 | 11.4 | 10.6 | 13.0 |
Exceeds LRDG chronic - among drinkers | 20.0 | 27.8 | 19.4 | 22.5 | 19.1 | 19.4 | 20.0 | 21.5 | 22.2 | 16.9 | 21.5 |
Exceeds LRDG acute - among drinkers | 15.4 | 21.5 | 13.8 | 17.8 | 13.2 | 13.5 | 16.2 | 16.8 | 15.4 | 13.9 | 16.7 |
Canada | NL | PE | NS | NB | QC | ON | MB | SK | AB | BC | |
---|---|---|---|---|---|---|---|---|---|---|---|
Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2015. |
|||||||||||
Male | 7,001 | 659 | 632 | 624 | 646 | 727 | 655 | 732 | 718 | 873 | 735 |
Female | 8,153 | 761 | 796 | 813 | 784 | 820 | 796 | 805 | 880 | 836 | 862 |
15-19 | 2,645 | 235 | 244 | 228 | 227 | 297 | 258 | 284 | 280 | 309 | 283 |
20-24 | 2,550 | 200 | 205 | 231 | 232 | 257 | 256 | 295 | 238 | 348 | 288 |
25+ | 9,959 | 985 | 979 | 978 | 971 | 993 | 937 | 958 | 1,080 | 1,052 | 1,026 |
25-34 | 1,394 | 115 | 93 | 105 | 109 | 136 | 125 | 156 | 198 | 195 | 162 |
35-44 | 1,582 | 146 | 140 | 147 | 131 | 180 | 154 | 156 | 173 | 201 | 154 |
45-54 | 1,884 | 207 | 190 | 189 | 187 | 188 | 182 | 192 | 175 | 194 | 180 |
55+ | 5,099 | 517 | 556 | 537 | 544 | 489 | 476 | 454 | 534 | 462 | 530 |
Total | 15,154 | 1,420 | 1,428 | 1,437 | 1,430 | 1,547 | 1,451 | 1,537 | 1,598 | 1,709 | 1,597 |
Page details
- Date modified: